Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

West Pharma EPS Jumps 22 Percent in Q2

TheMotleyFool 
0 0 24.07.25
West Pharma EPS Jumps 22 Percent in Q2
 

West Pharmaceutical Services (NYSE:WST), a global manufacturer of drug packaging and delivery systems for the pharmaceutical and healthcare industries, reported Q2 2025 earnings on July 24, 2025. The key news was a significant beat on both GAAP revenue and non-GAAP EPS. Adjusted earnings per share (EPS) were $1.84, outpacing the $1.51 analyst estimate (non-GAAP). Revenue reached $766.5 million, surpassing GAAP expectations of $726.1 million. Management also raised its full-year 2025 outlook for both net sales and adjusted diluted earnings per share. Overall, the quarter was marked by broad-based growth, margin improvement, and strong customer demand for the company’s proprietary products.

Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report.

West Pharmaceutical Services develops packaging and delivery systems used in the storage and administration of injectable drugs. Its products range from rubber stoppers and seals for vials, to advanced auto-injectors and wearable drug delivery devices for complex therapies. The company’s customer base includes biotech, pharmaceutical, and generic drug makers across the globe.

Continue reading


Source Fool.com

Electro Power Systems S.A. Stock

Show more
Like: 0
WST
Share

Comments

Not a member yet? Sign up for free!